Grace Therapeutics, Inc. · NASDAQ:GRCE
Opaleye Management Inc. bought 15,089 Grace Therapeutics, Inc. shares (Form 4/A)
Traded Sep 21 to Sep 23, 2026 · Filed Oct 1, 2026
From Sep 21 to Sep 23, 2026, Opaleye Management Inc. (10% owner) bought 15,089 Grace Therapeutics, Inc. shares at US$2.10 for US$31,687, leaving 2,790,318 shares. Filed Oct 1, 2026 (Form 4/A).
- Bought
- 15,089 shares
- Price
- US$2.10
- Value
- US$31,687
- Holding after
- 2,790,318 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock, par value $0.0001 per share | Buy | 9,771 | US$2.10 | 2,785,000 | Indirect |
| Sep 23, 2026 | Common Stock, par value $0.0001 per share | Buy | 5,318 | US$2.10 | 2,790,318 | Indirect |
Source
Related
- Grace Therapeutics, Inc.
- Opaleye Management Inc.
- Grace Therapeutics, Inc. shareholders
- Form 4 · Opaleye Management Inc. · Oct 21, 2026
- Form 4 · Opaleye Management Inc. · Oct 16, 2026
- Form 4 · Opaleye Management Inc. · Oct 13, 2026
- Form 4 · Opaleye Management Inc. · Oct 5, 2026
- Form 4 · Opaleye Management Inc. · Oct 1, 2026
- Form 4 · Opaleye Management Inc. · Sep 23, 2026
- Form 4 · Opaleye Management Inc. · Sep 10, 2026
- Form 4 · Kohli Prashant · Sep 10, 2026
- Form 4 · Opaleye Management Inc. · Aug 19, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026